Cited by 42T-cell and B-cell ImmunologyCancer Immunotherapy and BiomarkersTelomeres, Telomerase, and Senescence

Reversal of functional defects in highly differentiated young and old CD8 T cells by PDL blockade

Open access
Henson, Sian M., Macaulay, Richard, Franzese, Ornella, Akbar, Arne N.·2012·Immunology

Abstract

Highly differentiated CD8(+) CD28(-) CD27(-) T cells have short telomeres, defective telomerase activity and reduced capacity for proliferation. In addition, these cells express increased levels of inhibitory receptors and display defective Akt(ser(473)) phosphorylation following activation. It is not known whether signalling via programmed death 1 (PD-1) contributes to any of the attenuated differentiation-related functional changes in CD8(+) T cells. To address this we blocked PD-1 signalling during T-cell receptor (TCR) activation using antibodies against PD-1 ligand 1 (PDL1) and PDL2. This resulted in a significant enhancement of Akt(ser(473)) phosphorylation and TCR-induced proliferative activity of highly differentiated CD8(+) CD28(-) CD27(-) T cells. In contrast, the reduced telomerase activity in these cells was not altered by blockade of PDL1/2. We also demonstrate that PD-1 signalling can inhibit the proliferative response in primary human CD8(+) T cells from both young and older humans. These data collectively highlight that some, but not all, functional changes that arise during progressive T-cell differentiation and during ageing are maintained actively by inhibitory receptor signalling.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2567.2011.03550.x

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Henson, S. M., Macaulay, R., Franzese, O., & Akbar, A. N.
Affiliations
  • University College London (GB)
  • University of Rome Tor Vergata (IT)
Venue
Immunology
Publisher
Wiley
Published
2012-03-02
Volume
135
Issue
4
Pages
355-363
ISSN
  • 0019-2805 (ISSN-L)
  • 1365-2567
OpenAlex
W1585793952
Cited by
42
References
55
Citations by year
2026: 1 · 2025: 1 · 2024: 2 · 2023: 3 · 2022: 6 · 2021: 4 · 2020: 1 · 2019: 6 · 2018: 3 · 2017: 1 · 2016: 1 · 2015: 3 · 2014: 4 · 2013: 3 · 2012: 3
FWCI
1.42
Type
journal article
Language
en
Open access
Locations
  • Immunology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
  • UCL Discovery (University College London) (submittedVersion)
Funders
  • Directorate for Biological Sciences
  • Biotechnology and Biological Sciences Research Council (BB/J006750/1)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
Keywords
PD-L1, PD-L2, CD8+ T cells, T cell differentiation, telomerase activity, telomeres, Akt phosphorylation, T cell proliferation, inhibitory receptors, T cell receptor stimulation, immunosenescence
MeSH terms
Adult, Aged, Aged, 80 and over, Aging, Cell Differentiation, Humans, Lymphocyte Activation, Phosphorylation, CD28 Antigens, Tumor Necrosis Factor Receptor Superfamily, Member 7, CD8-Positive T-Lymphocytes, Proto-Oncogene Proteins c-akt, Young Adult, Programmed Cell Death 1 Receptor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review